8-K - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Filer)
Published . Updated .
Key takeaways
- 8-K - TEVA PHARMACEUTICAL INDUSTRIES filed an 8-K with the SEC on Nov 18 (a notice of a material company event).
- Exposed: TEVA
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
8-K - TEVA PHARMACEUTICAL INDUSTRIES filed an 8-K with the SEC on Nov 18 (a notice of a material company event).
Directly affected
- TEVA Teva Pharmaceutical Industries+4.2% 10d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- PFE Pfizer+5.2% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
- MRK Merck+3.5% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| TEVA | +3.44% | +0.85% | base | after close | after close | after close | after close |
| XLV | +3.66% | +3.71% | base | after close | after close | after close | after close |
| XBI | +4.22% | +0.59% | base | after close | after close | after close | after close |
| LLY | +3.43% | +3.72% | base | after close | after close | after close | after close |
| JNJ | +3.98% | +3.63% | base | after close | after close | after close | after close |
| PFE | +2.74% | +2.92% | base | after close | after close | after close | after close |
| MRK | +6.65% | +4.90% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-18 AccNo: 0001193125-26-467276 Size: 290 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation F…
Source: sec-edgar
Teva Pharmaceutical Industries (TEVA)
In the last 6 similar stories, Teva Pharmaceutical Industries (TEVA) moved an average of -0.85% the next day. The best was -0.85% and the worst was -0.85%, from 6 prices.
| Company | When | Average | Largest gain | Largest drop | Prices |
|---|---|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | the next day | -0.85% | -0.85% | -0.85% | 6 |
- UK imposes sanctions on Israeli firms involved in West Bank settlement construction
- Sa’ar vows Israeli countermeasures after UK sanctions firms, activist group
- Britain Sanctions Israeli Construction Firms Involved in Building Settlements
- Israel Building Center head slams UK sanctions on Israeli construction companies
- ‘Do not build’: UK sanctions 8 Israeli construction companies for building West Bank settlements
- UK sanctions eight Israeli construction firms over West Bank settlements
Teva Pharmaceutical Industries (TEVA) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| JNJ | three days earlier | +3.63% | final price |
| JNJ | five days earlier | +3.98% | final price |
| LLY | three days earlier | +3.72% | final price |
| LLY | five days earlier | +3.43% | final price |
| MRK | three days earlier | +4.90% | final price |
| MRK | five days earlier | +6.65% | final price |
| PFE | three days earlier | +2.92% | final price |
| PFE | five days earlier | +2.74% | final price |
| Teva Pharmaceutical Industries (TEVA) | three days earlier | +0.85% | final price |
| Teva Pharmaceutical Industries (TEVA) | five days earlier | +3.44% | final price |
| XBI | three days earlier | +0.59% | final price |
| XBI | five days earlier | +4.22% | final price |
| XLV | three days earlier | +3.71% | final price |
| XLV | five days earlier | +3.66% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 15 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 29 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 75 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 42 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 49 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 75 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 89 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Teva Pharmaceutical Industries (TEVA)
Companies mentioned with this story
- TEVA Teva Pharmaceutical Industries
For “8-K - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Filer),” Teva Pharmaceutical Industries (TEVA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> TEVA
Teva Pharmaceutical Industries (TEVA)
Teva Pharmaceutical Industries (TEVA) is the company in “8-K - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Filer),” the 18 Nov 2026 this story story.
Teva Pharmaceutical Industries (TEVA) is on the page because SEC 8-K filing -> direct issuer disclosure -> TEVA
Dates and price levels for Teva Pharmaceutical Industries (TEVA)
TEVA traded between 40.05 and 43.33 across 10 sessions. The latest close on file is 43.21.
How strong the case is around Teva Pharmaceutical Industries (TEVA)
14 out of 100
“8-K - TEVA PHARMACEUTICAL INDUSTRIES LTD (0000818686) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.